These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21342411

  • 1. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy.
    Rabbani N, Thornalley PJ.
    Diabetes Obes Metab; 2011 Jul; 13(7):577-83. PubMed ID: 21342411
    [Abstract] [Full Text] [Related]

  • 2. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
    Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ.
    Diabetes; 2003 Aug; 52(8):2110-20. PubMed ID: 12882930
    [Abstract] [Full Text] [Related]

  • 3. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 4. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
    Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ.
    Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
    [Abstract] [Full Text] [Related]

  • 5. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G, Macia M, Ruggenenti P.
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E, Brun JF, Fédou C, Puech-Cathala AM, Pérez-Martin A, Orsetti A.
    Ann Biol Clin (Paris); 1998 Apr; 56(6):671-9. PubMed ID: 9853026
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F, Bouiller M, Kolb I, Hannedouche T.
    Nephrologie; 2000 Apr; 21(2):47-55. PubMed ID: 10798204
    [Abstract] [Full Text] [Related]

  • 12. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM.
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [Abstract] [Full Text] [Related]

  • 13. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

  • 14. Preventing microalbuminuria in patients with type 2 diabetes.
    Jermendy G, Ruggenenti P.
    Diabetes Metab Res Rev; 2007 Feb; 23(2):100-10. PubMed ID: 17094161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
    Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL, Januszewicz A.
    J Hypertens; 2006 Feb; 24(2):403-8. PubMed ID: 16508590
    [Abstract] [Full Text] [Related]

  • 17. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J.
    Am J Nephrol; 2007 Feb; 27(5):495-502. PubMed ID: 17671379
    [Abstract] [Full Text] [Related]

  • 18. Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
    Cocchietto M, Zorzin L, Toffoli B, Candido R, Fabris B, Stebel M, Sava G.
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):587-94. PubMed ID: 18926757
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of diabetic nephropathy.
    Wittmann I, Molnár GA, Degrell P, Wagner Z, Tamaskó M, Laczy B, Brasnyó P, Wagner L, Nagy J.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.